Phio Pharmaceuticals Corp. (PHIO) Insider Trading

Phio Pharmaceuticals Corp. (PHIO)

Phio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States. It develops PH-762, an INTASYL compound designed to reduce the expression of PD-1 in multi-center Phase 1b dose-escalating clinical trials; PH-894, an INTASYL compound that is designed to specifically silence BRD4, a protein that controls gene expression in both T cells and tumor cells in preclinical studies. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was founded in 2003 and is based in King Of Prussia, Pennsylvania.

Showing latest transactions and SEC Form 4 filings for PHIO.

12 results.

X Filing Date Trade Date Ticker Company Name Insider Name Title Trade Type Price Qty Owned ΔOwn Value
M 2026-11-16 10:30:03 2026-11-13 PHIO Phio Pharmaceuticals Corp. Deming David H Director P - Purchase $0.82 +12,000 120,600 +3% +$9,823
M 2026-11-12 09:52:24 2026-11-11 PHIO Phio Pharmaceuticals Corp. Deming David H Director P - Purchase $0.84 +12,000 94,400 +6% +$10,066
2026-11-10 11:18:44 2026-11-09 PHIO Phio Pharmaceuticals Corp. Plott Ronald Todd Director P - Purchase $0.83 +18,300 60,300 +44% +$15,189
2026-11-10 11:17:16 2026-11-09 PHIO Phio Pharmaceuticals Corp. Bitterman Robert J Chairman, Pres. & CEO, Director P - Purchase $0.82 +25,000 789,871 +3% +$20,500
M 2026-09-30 16:01:04 2026-09-29 PHIO Phio Pharmaceuticals Corp. Plott Ronald Todd Director P - Purchase $1.04 +10,000 79,000 +7% +$10,350
2026-09-29 16:01:07 2026-09-28 PHIO Phio Pharmaceuticals Corp. Carson Lisa Cabott Chief Financial Officer A $0.00 +108,000 189,112 0% $0
2026-09-29 16:01:05 2026-09-28 PHIO Phio Pharmaceuticals Corp. Bitterman Robert J Chairman, Pres. & CEO, Director A $0.00 +400,000 764,871 0% $0
2026-09-29 16:01:04 2026-09-28 PHIO Phio Pharmaceuticals Corp. Plott Ronald Todd Director A $0.00 +17,000 32,000 0% $0
2026-09-25 16:01:23 2026-09-24 PHIO Phio Pharmaceuticals Corp. BRADFORD PATRICIA A Director P - Purchase $1.01 +6,500 64,151 +11% +$6,583